Report workspace tools

NCT00018200COMPLETEDanonymous

Efficacy of Antidepressants in Chronic Back Pain

Sponsor

Source record

US Department of Veterans Affairs

Phase

Source record

PHASE2

Modality

AI-normalized

small molecule

Target

AI-normalized

Desipramine, Fluoxetine, Benztropine

Indication / condition

AI-normalized

Back Pain

Intervention

Source record

Desipramine, Fluoxetine, Benztropine

Source & freshness

Source record

NCT ID

NCT00018200

Original source

ClinicalTrials.gov

Source last updated

Jun 05, 2012

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT00018200

Title

Efficacy of Antidepressants in Chronic Back Pain

Sponsor

US Department of Veterans Affairs

Status

COMPLETED

Phase

PHASE2

Condition raw

Back Pain, Sciatica

Condition normalized

Back Pain, Sciatica

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Desipramine, Fluoxetine, Benztropine

Target normalized

Desipramine, Fluoxetine, Benztropine

Interventions

Desipramine, Fluoxetine, Benztropine

Public preview

Source record

The purpose of this study is to determine whether different types of antidepressant medicines relieve back pain that has lasted at least six months on a daily basis. Study participants will be assigned to treatment with either a antidepressant acting on the serotonin system in the brain (fluoxetine), one acting on the noradrenaline system (desipramine, or to a control medication not expected to relieve pain (benztropine). Each participant will be seen at least nine times during their 12 weeks on medication. This is a phase 2/3, outpatient study.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account

Create a free account first, then unlock a single report, buy credits or subscribe.